Abstract
Background. Continuous Veno-Venous hemofiltration (CVVH) in the case of sepsis is often used as extracorporeal detoxification method and it is initiated before patients develop absolute indications. So far it is not clear, whether the use of CVVH as the method of detoxification for sepsis patients does influence the indicators of recovery. Aim of study is to describe hazard ratio of CVVH initiation for short-term (7 days) and long-term (28 days) outcomes in sepsis patients.
Methods. A retrospective study of 127 patients who were treated at Riga East Clinical University Hospital’s with diagnosis “sepsis” during the time period from 2014 to 2017 and in whom (CVVH) was used. SPSS software was used to analyze data, and hazard ratio (HR) was calculated using Cox regression method.
Results. Among study patients 47.2% (60/127) were males, median of age 68 years (IQR 58-76). All patients were divided into two groups according to CVVH initiation criteria: 63/124 (49.6%) had absolute indications and 64/124 (50.4%) had relative indications. On the 7th day and on the 28th day of hospital admission survival rates for sepsis patients were 83/127 (65.4%) and 53/127 (41.7%), respectively. During all hospital length of stay survival rate of sepsis patients was 47/127 (37.0%). For the short-term and long-term outcomes initiation of CRRT based on the absolute indications was associated with higher mortality rates HR=2.19 (95%CI=1.17-4.08) and HR=2.08 (95%CI=1.30-3.34), respectively, in comparison to relative indications. After adjustment to other prognostic factors (sepsis origin, need of mechanical lung ventilation, SOFA score, lactate concentration etc.) only long-term higher mortality
rates showed significant association with CRRT initiation based on absolute indications HR=1.96 (95%CI=1.08-3.56).
Conclusions. Early initiation of CVVH in septic patients based on relative indications may improve long-term patient survival.
Methods. A retrospective study of 127 patients who were treated at Riga East Clinical University Hospital’s with diagnosis “sepsis” during the time period from 2014 to 2017 and in whom (CVVH) was used. SPSS software was used to analyze data, and hazard ratio (HR) was calculated using Cox regression method.
Results. Among study patients 47.2% (60/127) were males, median of age 68 years (IQR 58-76). All patients were divided into two groups according to CVVH initiation criteria: 63/124 (49.6%) had absolute indications and 64/124 (50.4%) had relative indications. On the 7th day and on the 28th day of hospital admission survival rates for sepsis patients were 83/127 (65.4%) and 53/127 (41.7%), respectively. During all hospital length of stay survival rate of sepsis patients was 47/127 (37.0%). For the short-term and long-term outcomes initiation of CRRT based on the absolute indications was associated with higher mortality rates HR=2.19 (95%CI=1.17-4.08) and HR=2.08 (95%CI=1.30-3.34), respectively, in comparison to relative indications. After adjustment to other prognostic factors (sepsis origin, need of mechanical lung ventilation, SOFA score, lactate concentration etc.) only long-term higher mortality
rates showed significant association with CRRT initiation based on absolute indications HR=1.96 (95%CI=1.08-3.56).
Conclusions. Early initiation of CVVH in septic patients based on relative indications may improve long-term patient survival.
Original language | English |
---|---|
Pages | 28 |
Number of pages | 1 |
Publication status | Published - Oct 2018 |
Event | 9th International Baltic Congress of Anaesthesiology, Intensive Care and Pain Management - Vilnius, Lithuania Duration: 25 Oct 2018 → 27 Oct 2018 Conference number: 9 https://healthmanagement.org/c/icu/event/9th-international-baltic-congress-of-anaesthesiology-intensive-care-and-pain-management |
Congress
Congress | 9th International Baltic Congress of Anaesthesiology, Intensive Care and Pain Management |
---|---|
Country/Territory | Lithuania |
City | Vilnius |
Period | 25/10/18 → 27/10/18 |
Internet address |
Field of Science*
- 3.2 Clinical medicine
- 3.1 Basic medicine
Publication Type*
- 3.4. Other publications in conference proceedings (including local)